Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

30.85
Delayed Data
As of 3:59pm ET
 -1.64 / -5.05%
Today’s Change
14.83
Today|||52-Week Range
63.73
+12.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues0.000.005.4M16.3M
 
 
 
Cost of Goods Sold0.000.00130.0K252.0K
 
 
 
Depreciation And Amortization1.5M1.1M1.7M1.6M
 
 
 
 
 
 
Operating ExpensesGross Income-1.5M-1.1M3.6M14.5M
 
 
 
 
 
General Expenses60.0M54.2M92.0M53.5M
 
 
 
 
 
Research And Development43.8M33.6M70.7M29.0M
 
 
 
 
 
Total Operating Expenses61.5M55.3M93.8M55.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-61.5M-55.3M-88.4M-39.0M
 
 
 
 
 
Extraordinary Credit0.000.000.00125.0M
 
 
Extraordinary Charge-626.0K-1.3M0.00-236.0K
 
 
 
 
Interest Expense On Debt201.0K209.0K57.0K--
 
 
 
 
Other Expenses0.000.000.00335.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-62.3M-56.7M-88.5M86.1M
 
 
 
 
 
Income Taxes0.000.000.00-2.0M
 
 
Net Income-62.3M-56.7M-88.5M84.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS46.2M48.3M54.6M54.9M
 
 
 
 
 
Shares To Calculate EPS Diluted46.2M48.3M54.6M56.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.35-$1.18-$1.62$1.50
 
 
 
 
 
EPS Diluted-$1.35-$1.18-$1.62$1.50